Dr. Jasvinder Singh is a Professor of medicine and epidemiology at the University of Alabama at Birmingham, Director of the Gout Clinic at the University of Alabama Health Sciences Foundation and a staff rheumatologist at the Birmingham Veterans Affairs Medical Center. His research has focused on studies of outcomes in patients with rheumatic diseases, using databases and performing interventional studies to improve outcomes in patients with rheumatic diseases. Dr. Singh's previous studies have focused on assessing correlates and predictors of patient-reported outcomes (PROs) including quality of life, pain, and function in large cohorts of patients with arthritis.
Dr. Singh is the principal investigator on a PCORI-funded study to develop and test the efficacy of a patient decision aid for immunosuppressive medication decision making in minorities with lupus kidney disease. He is also investigating whether patient-focused interventions can improve outcomes in patients with gout. Dr. Singh is using new statistical methodology of network meta-analyses, to help synthesize the vast information from multiple systematic reviews. He led the development of the 2012 and 2015 American College of Rheumatology treatment guidelines for RA, and is an active contributor to development of several ACR treatment guidelines and development of classification and response criteria.